{"id":"https://openalex.org/W2945540985","doi":"https://doi.org/10.23736/s0026-4784.19.04249-7","title":"Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study","display_name":"Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study","publication_year":2019,"publication_date":"2019-05-01","ids":{"openalex":"https://openalex.org/W2945540985","doi":"https://doi.org/10.23736/s0026-4784.19.04249-7","mag":"2945540985","pmid":"https://pubmed.ncbi.nlm.nih.gov/30727721"},"language":"en","primary_location":{"id":"doi:10.23736/s0026-4784.19.04249-7","doi":"https://doi.org/10.23736/s0026-4784.19.04249-7","is_oa":false,"landing_page_url":"https://doi.org/10.23736/s0026-4784.19.04249-7","pdf_url":null,"source":{"id":"https://openalex.org/S4210228202","display_name":"Minerva Obstetrics and Gynecology","issn_l":"0026-4784","issn":["0026-4784","1827-1650","2724-606X","2724-6450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4320800528","host_organization_name":"Edizioni Minerva Medica","host_organization_lineage":["https://openalex.org/P4320800528"],"host_organization_lineage_names":["Edizioni Minerva Medica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Minerva Ginecologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033784311","display_name":"John Syrios","orcid":"https://orcid.org/0000-0003-0877-7773","observed_orcids":["https://orcid.org/0000-0003-0877-7773"]},"institutions":[{"id":"https://openalex.org/I4210126215","display_name":"Hellenic Oncology Research Group","ror":"https://ror.org/034yqx295","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210126215"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"John Syrios","raw_affiliation_strings":["Hellenic Oncology Research Group (HORG), Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hellenic Oncology Research Group (HORG), Athens, Greece","institution_ids":["https://openalex.org/I4210126215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060929404","display_name":"Charalambos Kouroussis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126215","display_name":"Hellenic Oncology Research Group","ror":"https://ror.org/034yqx295","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210126215"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Charalambos Kouroussis","raw_affiliation_strings":["Hellenic Oncology Research Group (HORG), Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hellenic Oncology Research Group (HORG), Athens, Greece","institution_ids":["https://openalex.org/I4210126215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084377238","display_name":"Athanasios Panayotis Kotsakis","orcid":"https://orcid.org/0000-0002-5530-6774","observed_orcids":["https://orcid.org/0000-0002-5530-6774"]},"institutions":[{"id":"https://openalex.org/I4210126215","display_name":"Hellenic Oncology Research Group","ror":"https://ror.org/034yqx295","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210126215"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Athanasios Kotsakis","raw_affiliation_strings":["Hellenic Oncology Research Group (HORG), Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hellenic Oncology Research Group (HORG), Athens, Greece","institution_ids":["https://openalex.org/I4210126215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087963010","display_name":"Nikolaos K. Kentepozidis","orcid":"https://orcid.org/0000-0002-6037-5707","observed_orcids":["https://orcid.org/0000-0002-6037-5707"]},"institutions":[{"id":"https://openalex.org/I4210126215","display_name":"Hellenic Oncology Research Group","ror":"https://ror.org/034yqx295","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210126215"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Nikolaos Kentepozidis","raw_affiliation_strings":["Hellenic Oncology Research Group (HORG), Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hellenic Oncology Research Group (HORG), Athens, Greece","institution_ids":["https://openalex.org/I4210126215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074069899","display_name":"Emmanouil Kontopodis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126215","display_name":"Hellenic Oncology Research Group","ror":"https://ror.org/034yqx295","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210126215"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Emmanouil Kontopodis","raw_affiliation_strings":["Hellenic Oncology Research Group (HORG), Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hellenic Oncology Research Group (HORG), Athens, Greece","institution_ids":["https://openalex.org/I4210126215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046050577","display_name":"Kostas Kalbakis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126215","display_name":"Hellenic Oncology Research Group","ror":"https://ror.org/034yqx295","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210126215"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Kostas Kalbakis","raw_affiliation_strings":["Hellenic Oncology Research Group (HORG), Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hellenic Oncology Research Group (HORG), Athens, Greece","institution_ids":["https://openalex.org/I4210126215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023034870","display_name":"Nikolaos Vardakis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126215","display_name":"Hellenic Oncology Research Group","ror":"https://ror.org/034yqx295","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210126215"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Nikolaos Vardakis","raw_affiliation_strings":["Hellenic Oncology Research Group (HORG), Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hellenic Oncology Research Group (HORG), Athens, Greece","institution_ids":["https://openalex.org/I4210126215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065290885","display_name":"Dora Hatzidaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126215","display_name":"Hellenic Oncology Research Group","ror":"https://ror.org/034yqx295","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210126215"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Dora Hatzidaki","raw_affiliation_strings":["Hellenic Oncology Research Group (HORG), Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hellenic Oncology Research Group (HORG), Athens, Greece","institution_ids":["https://openalex.org/I4210126215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054375277","display_name":"Aris Polyzos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126215","display_name":"Hellenic Oncology Research Group","ror":"https://ror.org/034yqx295","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210126215"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Aris Polyzos","raw_affiliation_strings":["Hellenic Oncology Research Group (HORG), Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hellenic Oncology Research Group (HORG), Athens, Greece","institution_ids":["https://openalex.org/I4210126215"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109085965","display_name":"Vassilis Georgoulias","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126215","display_name":"Hellenic Oncology Research Group","ror":"https://ror.org/034yqx295","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210126215"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Vassilis Georgoulias","raw_affiliation_strings":["Hellenic Oncology Research Group (HORG), Athens, Greece - georgsec@med.uoc.gr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hellenic Oncology Research Group (HORG), Athens, Greece - georgsec@med.uoc.gr","institution_ids":["https://openalex.org/I4210126215"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210126215"],"apc_list":null,"apc_paid":null,"fwci":0.2238,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.53672418,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"71","issue":"3","first_page":"182","last_page":"190"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.8330000042915344},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.9350000023841858},{"id":"https://openalex.org/keywords/salvage-chemotherapy","display_name":"salvage chemotherapy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/weekly-chemotherapy","display_name":"weekly chemotherapy","score":0.6169999837875366},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8069999814033508},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9769999980926514},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9160000085830688},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/high-grade-serous-ovarian-carcinoma","display_name":"high-grade serous ovarian cancer","score":0.8569999933242798},{"id":"https://openalex.org/keywords/metastatic-ovarian-cancer","display_name":"metastatic ovarian cancer","score":0.7860000133514404},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6039999723434448}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9533329010009766},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9294263124465942},{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.9075973033905029},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7646071314811707},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6538307070732117},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6483591794967651},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5949491262435913},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.47821399569511414},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4721679091453552},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.45136335492134094},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4260461628437042},{"id":"https://openalex.org/C3019864225","wikidata":"https://www.wikidata.org/wiki/Q5867482","display_name":"Combination chemotherapy","level":3,"score":0.42499616742134094},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4216071665287018},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3924205005168915},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38068071007728577},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35168933868408203}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.23736/s0026-4784.19.04249-7","doi":"https://doi.org/10.23736/s0026-4784.19.04249-7","is_oa":false,"landing_page_url":"https://doi.org/10.23736/s0026-4784.19.04249-7","pdf_url":null,"source":{"id":"https://openalex.org/S4210228202","display_name":"Minerva Obstetrics and Gynecology","issn_l":"0026-4784","issn":["0026-4784","1827-1650","2724-606X","2724-6450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4320800528","host_organization_name":"Edizioni Minerva Medica","host_organization_lineage":["https://openalex.org/P4320800528"],"host_organization_lineage_names":["Edizioni Minerva Medica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Minerva Ginecologica","raw_type":"journal-article"},{"id":"pmid:30727721","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30727721","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Minerva ginecologica","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W95856701","https://openalex.org/W1901524790","https://openalex.org/W1913802169","https://openalex.org/W1924537290","https://openalex.org/W1960327677","https://openalex.org/W1976006503","https://openalex.org/W1981099237","https://openalex.org/W1982083188","https://openalex.org/W1985953095","https://openalex.org/W1993215007","https://openalex.org/W1994403006","https://openalex.org/W2012171803","https://openalex.org/W2019607817","https://openalex.org/W2023001146","https://openalex.org/W2039122312","https://openalex.org/W2041178952","https://openalex.org/W2054638722","https://openalex.org/W2068325902","https://openalex.org/W2072871546","https://openalex.org/W2085944495","https://openalex.org/W2115954319","https://openalex.org/W2119148287","https://openalex.org/W2123113463","https://openalex.org/W2124058261","https://openalex.org/W2127520577","https://openalex.org/W2134947875","https://openalex.org/W2135594199","https://openalex.org/W2141048775","https://openalex.org/W2145445267","https://openalex.org/W2145660724","https://openalex.org/W2145981575","https://openalex.org/W2154737435","https://openalex.org/W2155126523","https://openalex.org/W2164193849","https://openalex.org/W2165862201","https://openalex.org/W2165948908","https://openalex.org/W2166858780","https://openalex.org/W2170845869","https://openalex.org/W2171318838","https://openalex.org/W2310556229","https://openalex.org/W2342542764","https://openalex.org/W2344322811","https://openalex.org/W2344919561","https://openalex.org/W2346052414","https://openalex.org/W2400499697","https://openalex.org/W4238631637","https://openalex.org/W4406660574"],"related_works":["https://openalex.org/W1987409084","https://openalex.org/W2014088721","https://openalex.org/W2020575152","https://openalex.org/W2145660724","https://openalex.org/W2015563786","https://openalex.org/W2965694017","https://openalex.org/W2003127499","https://openalex.org/W2023001146","https://openalex.org/W1991260809","https://openalex.org/W95856701"],"abstract_inverted_index":{"BACKGROUND:":[0],"Evaluation":[1],"of":[2,4,42,50,73,104,127,143,151,163,183,219],"safety":[3],"the":[5,32,70,74,79,155,175,184],"weekly":[6,217],"intravenous":[7],"gemcitabine/topotecan":[8,220],"combination":[9,75,185],"as":[10],"salvage":[11],"treatment":[12,111],"in":[13,31,88,222,235],"patients":[14,85,92,109,223],"with":[15,23,39,48,124,170,224,239],"recurrent":[16],"epithelial":[17],"ovarian":[18,26,97,227],"cancer.":[19],"METHODS:":[20],"Twenty-four":[21,83],"women":[22],"histologically-proven":[24],"relapsed":[25],"cancer":[27,98,228],"(ROC)":[28],"were":[29,53,76,86,122,154,186,211],"enrolled":[30,87],"study.":[33],"Topotecan":[34],"(1.75":[35],"mg/m2":[36,47,189,193],"IV)":[37],"along":[38],"escalated":[40],"doses":[41,182],"gemcitabine":[43,191],"(starting":[44],"dose":[45,67],"700":[46],"increments":[49],"100":[51],"mg/m2)":[52],"administered":[54,123],"on":[55,194],"days":[56,195],"1,":[57,196],"8,":[58,197],"and":[59,69,100,115,137,141,147,190,198,206],"15":[60,199],"every":[61,200],"28":[62,201],"days.":[63,202],"The":[64,132,179,216],"maximum":[65],"tolerated":[66],"(MTD)":[68],"dose-limiting":[71],"toxicity":[72,167,242],"evaluated":[77],"at":[78],"first":[80],"cycle.":[81],"RESULTS:":[82],"ROC":[84],"six":[89],"dose-levels.":[90],"Most":[91],"had":[93],"high-grade":[94],"serous":[95],"metastatic":[96,226],"(41.7%)":[99],"performance":[101],"status":[102],"score":[103],"0-1":[105],"(95.8%).":[106],"For":[107],"12":[108,117],"(50%)":[110],"was":[112,134,160,168],"2nd":[113],"line":[114],"for":[116],">2nd":[118],"line.":[119],"Eighty-eight":[120],"cycles":[121,129],"a":[125,240],"median":[126],"three":[128,207],"per":[130],"patient.":[131],"MTD":[133,181],"not":[135],"reached":[136],"grade":[138,148,171],"3-4":[139],"(3.4%":[140,150],"2.3%":[142],"cycles,":[144],"respectively)":[145],"neutropenia":[146],"4":[149],"cycles)":[152],"thrombocytopenia":[153],"main":[156],"adverse":[157],"events.":[158],"There":[159],"no":[161],"case":[162],"febrile":[164],"neutropenia.":[165],"Non-hematologic":[166],"mild":[169],"2":[172],"fatigue":[173],"being":[174],"most":[176],"frequent":[177],"complain.":[178],"recommended":[180],"topotecan":[187],"1.75":[188],"1200":[192],"Two":[203],"complete":[204],"(8.3%)":[205],"(12.5%)":[208],"partial":[209],"responses":[210],"achieved":[212],"(ORR:":[213],"20.8%).":[214],"CONCLUSIONS:":[215],"administration":[218],"regimen":[221],"pretreated":[225,237],"is":[229],"an":[230],"active":[231],"chemotherapy":[232],"combination,":[233],"even":[234],"heavily":[236],"patients,":[238],"manageable":[241],"profile":[243],"which":[244],"merits":[245],"further":[246],"investigation.":[247]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-05-29T00:00:00"}